TSB-9-W1, NCT02249650: To Determine the MTD and to Evaluate the Safety, Efficacy and PK Profiles of in Pre-treated Patients With mCRC. |
|
|
| Completed | 1 | 21 | RoW | TSB-9-W1, TSB-9-W1(IDS) | Taiwan Sunpan Biotechnology Development Co., Ltd., Virginia Contract Research Organization Co., Ltd. | Metastatic Colorectal Cancer | 02/20 | 08/20 | | |
